Top 5 Life Science Startup Investors in Ireland
A list of 5 angel investors and VC funds that invest in Life science startups based in Ireland. We rank investors based on the number of investments they made in Life science companies from Ireland. We update this investor list every month.Top 5 Life Science Startup Investors in Ireland
Investor | Life Science Ireland investments |
---|---|
Enterprise Ireland | 6 |
AIB Seed Capital Fund | 5 |
KBI Biopharma | 1 |
European Investment Bank | 1 |
Western Development Commission | 1 |
Enterprise Ireland is the government agency responsible for the development and funding of the indigenous business sector. Their mission is to accelerate the development of companies to achieve strong positions in global markets resulting in increased national and regional prosperity.
It was founded in 1998 and headquartered in Dublin, Ireland.
Show more
Investment focus
- Software, Health Care, Information Technology
- Funding Round, Seed, Series A
- Ireland, United States, United Kingdom
Portfolio highlights
- Lative — Lative automates capacity planning, maximizing profitable sales growth & revenue efficiency for high-performance revenue teams.
- Cytidel — Cytidel helps security teams reduce breaches, save time, and stay secure. Vulnerability Management and Cyber Risk Management, and Threat Intelligence Specialists
- Positive Carbon — Positive Carbon provides an innovative solution for businesses to track, manage, and reduce food waste. With real-time analytics, CO2 calculation, and a comprehensive learning platform, we help you save costs and achieve sustainability goals. Request a demo today to start making a positive environmental impact.
The AIB Seed Capital Fund was established in 2007 to provide venture capital for companies at the seed and early stages of development across a range of sectors throughout the Republic of Ireland. The Fund was established under the Enterprise Ireland Seed and Venture Capital Programme 2007-2012.The Fund has a total of €30m under managementwith AIB and Enterprise Ireland both committing €15m. It is managed by experienced managers with extensive expertise in making seed and early stage investments, adding value and facilitating business success.The Fund managers are empowered to make seed investments of up to approximately €500,000. Furthermore, the Fund has the capacity to make investments in later rounds to support the continued growth of investee companies.The Fund will be managed by Enterprise Equity Venture Capital and the Dublin Business Innovation Centre. This unique partnership brings together extensive regional and investment expertise.Enterprise Equity will evaluate and manage all investments outside the city and county of Dublin, as well as investments that require in excess of €250,000 from the fund within the city and county of Dublin.Dublin Business Innovation Centre (DBIC) will evaluate and manage all investments within the city and county of Dublin when the initial investment amount required from the Fund does not exceed €250,000.
Show more
Investment focus
- Software, Health Care, Medical
- Seed, Funding Round, Series A
- Ireland, United States, Jersey
Portfolio highlights
- NewsWhip — The only real-time media monitoring platform that predicts the stories and topics that will matter in the hours ahead.
- Offr — Offr is the new way to buy and sell property, quickly and transparently.
- Metabolomic Diagnostics — Metabolomic Diagnostics is a deep-tech company specialized in the development of novel biomarker based diagnostic solutions for complex diseases. The company has developed an effective pipeline to firstly identify diagnostic biomarker panels and then translate these panels into clinical assays ready for application in the clinical laboratory.Thispipeline combines the biomarker multiplexing capabilities of Mass Spectrometry, a powerful analytical technology, with the company’s own informatics and statistics solutions to deliver diagnostic innovation. This is reflected in Metabolomic Diagnostics’ strong and versatile IP portfolio of technical innovations and biomarkers.Our VisionMetabolomic Diagnostics’ primary vision is to develop a portfolio of diagnostic solutions which can determine, early in a woman’s pregnancy,her risk of developing major complications much later in her pregnancy and thus enabling personalized care, adapted to each woman’s individual needs. Pregnancy complications like preeclampsia, gestational diabetes, preterm birth, and in-uterine growth restriction, all have the potential to severely impact on the well-being of mother and child.The company’s innovative diagnostic solutions will assist clinicians in re-imagining how these conditions are managed: our novel risk assessment tools are specifically developed in conjunction with prenatal care providers to ensure they make a difference that really matters. This in turn will enable clinicians to improve pregnancy outcomes globally.Our solutions will empower pregnant women: accurate pregnancy risk information will allow a pregnant woman, in partnership with her care provider, to determine what prenatal care is best for her pregnancy.
KBI Biopharma is an award-winning biopharmaceutical contract services organization providing fully-integrated, accelerated drug development and biomanufacturing services to pharmaceutical and biotechnology companies globally.With each of our 300+ client partners, we have worked closely to personalize and rapidly accelerate their drug developmentprograms. Built upon a foundation of world-class analytical capabilities, we deliver efficient process development and clinical and commercial cGMP manufacturing services for mammalian, microbial, and cell therapy programs.We have locations in Durham and Research Triangle Park (NC), Boulder and Louisville (CO), The Woodlands (TX), San Diego (CA), and Leuven, Belgium.
Show more
Investment focus
- Biotechnology, Life Science, Medical
- Seed, Series A, Series D
- United States, Ireland
Portfolio highlights
- Absci — A better, faster path to new medicines. We translate ideas into drugs with an AI-powered approach to biologic drug discovery and cell line development.
- GlycoSeLect — GlycoSeLect Ltd specialises in the development and production of Recombinant Prokaryotic Lectins (RPLs).
- ReForm Biologics — ReForm Biologics is an engineering superior biotherapeutic formulation for fragile patients. Its proprietary technology provides patented, FDA-friendly excipients for a wide range of therapeutic biologics. Using its platforms, drug companies can make life-saving medicines easier to administer, less immunogenic, more stable, and more efficient toproduce. It was founded in 2014 and is based in Woburn, Massachusetts.
European Investment Bank (EIB) provides lending, borrowing, and treasury services primarily in the European Union.The company offers project loans for the public and private sectors; loans to banks and other intermediaries; structured finance products; guarantees and securitization instruments for senior and subordinated debts; project bonds;equity and fund investment products such as infrastructure equity and debt funds, and environmental funds; and venture capital funds and security packages for funds.The company also offers microfinance; risk sharing finance for research, development, and innovation projects; finance and technical expertise for sustainable energy projects; infrastructure project advisory services; support for urban development projects; guarantees for transport infrastructure; and funding for public-private partnerships and small- and medium-sized enterprises.EIB serves the transportation, global loans, energy, industry, health, education, water, sewerage, infrastructure, services, telecommunications, agriculture, and fisheries sectors.European Investment Bank was founded in 1958 and is based in Luxembourg.
Show more
Investment focus
- Biotechnology, Health Care, Software
- Debt Financing, Post-IPO Debt, Funding Round
- France, Germany, The Netherlands
Portfolio highlights
- Eldrive — The largest charging point operator in Eastern Europe | Our network is expanding rapidly yet our focus is fixed on renewables, for a greener future. We provide AC & DC charging across Bulgaria, Romania and Lithuania.
- ABN AMRO Bank — Als bank leggen wij de focus op inclusiviteit, duurzaamheid, sociaal ondernemen, innovatie, dagelijkse bankzaken en meer.
- Enel Green Power — Enel Green Power is the company that deals with renewable energy from every perspective: from direct sales through PPA, to commitment at the forefront with its plants worldwide.
Supporting communities to grow, investing in businesses to scale and planning for the future of the western region.
Show more
Investment focus
- Health Care, Medical Device, Biotechnology
- Seed, Funding Round, Series A
- Ireland, United States
Portfolio highlights
- FeelTect — Connected health technology for disruptive improvements to wound care
- CitySwift — CitySwift is a data-driven scheduling and planning technology for urban bus networks. It uses artificial intelligence and machine learning to predict journey times and passenger demand, making routes more efficient. Schedulers can create optimized timetables that take into account traffic, events, and hundreds of other external factors, ensuringon-time performance and increased passenger satisfaction.CitySwift was established in 2016 and is operating in Galway, Ireland.
- Amara Therapeutics — Amara Therapeutics is passionate about empowering women and men to take control of their pelvic health. Amara Therapeutics use evidence based medicine and behavioural interventions supported by Amara Therapeutics platform of technologies to provide safe, convenient and non-invasive care pathways. At Amara Therapeutics mission is to fix the carepathway for pelvic health patients, connecting healthcare providers, patients and peers through our platform.
Investors by industry
Health Care
Biotech
Community
Marketplace
FinTech
Impact
Proptech
Media (entertainment)
EdTech
Consumer
Climate
Energy
Hardware
Gaming
Artificial intelligence
Sustainability
Agriculture (agtech)
Venture Capital
Restaurants
Publishing
Beauty
Oil and Gas
Web3
Video Games
Food and Beverage
Clean Energy
Real Estate
Infrastructure
Big Data
Organic Food
Medical
Email
Wellness
Social Media
Music
Franchise
Celebrity
Android
Internet
Legal
Google
eSports
Construction
Local
Mobile
Enterprise Software
Sports
Social Network
Manufacturing
Digital Media
Facebook
Art
Social Impact
Recruiting
Platforms
Travel
Fitness
Mobile Advertising
Cannabis
Biotechnology
Hospitality
Automotive
Crowdfunding
Wine And Spirits
Medical Device
Social
CleanTech
Transportation
Mobile Apps
InsurTech
Enterprise
Photography
LGBT
Fashion
Education
B2B
Renewable Energy
Payments
Financial Services
Sporting Goods
Finance
Retail
Film
Life Science
Theatre
Non Profit
SaaS
Software
Cryptocurrency
Blockchain
Investors by country
Canada
United Kingdom
Ireland
Germany
South Korea
Australia
United States
India
New Zealand
Oceania
Armenia
China
Europe
Indonesia
LATAM
Middle East
Spain
Asia
Japan
South Africa
Qatar
Vietnam
Saudi Arabia
Singapore
Sri Lanka
Brazil
Africa
Czech Republic
Bahrain
Belize
Bermuda
Costa Rica
Belarus
Bulgaria
Denmark
Algeria
Georgia
Gibraltar
Cameroon
Chile
Kuwait
Israel
Jersey
Kazakhstan
Nicaragua
Philippines
Italy
Mali
Lithuania
Cambodia
Liechtenstein
Kenya
Liberia
Lebanon
Mauritius
Morocco
Malaysia
Norway
Peru
Myanmar
Cayman Islands
Panama
Malta
Mexico
Seychelles
Slovenia
Russian Federation
Rwanda
Serbia
Uzbekistan
Togo
Taiwan
Ukraine
Sierra Leone
Turkey
Tunisia
Thailand
Tajikistan
Poland
Uganda
Zimbabwe
Tanzania
San Marino
Uruguay
Venezuela
Zambia
Senegal
Puerto Rico
Portugal
Sweden
El Salvador
Nigeria
Bahamas
Azerbaijan
Iraq
Iceland
Namibia
United Arab Emirates
Honduras
Isle of Man
Bolivia
Luxembourg
Pakistan
Albania
Finland
Estonia
Argentina
Bangladesh
Faroe Islands
Grenada
Jordan
Romania
Austria
Greece
Ethiopia
Ghana
Hungary
Croatia
Egypt
Belgium
Barbados
Ecuador
France
Hong Kong
Cyprus
Latvia
Oman
Colombia
Switzerland
Guatemala
Marshall Islands
Investors in Ireland by industry
FinTech
Enterprise
Transportation
Consumer
Health Care
EdTech
Climate
Biotech
Impact
SaaS
Proptech
Artificial intelligence
Agriculture (agtech)
Hardware
Gaming
Marketplace
Restaurants
Construction
Mobile Apps
Real Estate
Cryptocurrency
Payments
Finance
InsurTech
Food and Beverage
Video Games
Wine And Spirits
Renewable Energy
Medical
Medical Device
CleanTech
Wellness
Social Network
Social Media
Art
Manufacturing
Music
Digital Media
Android
Mobile
Local
Non Profit
Social Impact
Legal
Software
Sports
Enterprise Software
Fitness
Travel
Automotive
Hospitality
Recruiting
B2B
Platforms
Biotechnology
Retail
Fashion
Web3
Life Science
Blockchain
Photography
Publishing
Big Data
Education
Clean Energy
Oil and Gas
Internet
Sustainability
Energy
Financial Services
Media (entertainment)
Community